eosine yellowish-(ys) has been researched along with Non-alcoholic Fatty Liver Disease in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 4 (100.00) | 2.80 |
Authors | Studies |
---|---|
Feng, Y; Liu, H; Ping, J; Wen, X; Xu, D; Zhao, W | 1 |
Dong, Y; Shen, S; Wang, K; Zhi, Y | 1 |
Chalasani, N; Cummings, OW; Gawrieh, S; Kleiner, DE; Sethunath, D; Tuceryan, M; Vuppalanchi, R | 1 |
Andersen, MJ; Azizgolshani, N; Bobak, CA; Christensen, BC; Levy, JJ; Lisovsky, M; Liu, X; Ren, B; Suriawinata, A; Vaickus, LJ | 1 |
4 other study(ies) available for eosine yellowish-(ys) and Non-alcoholic Fatty Liver Disease
Article | Year |
---|---|
Pentoxifylline attenuates nonalcoholic fatty liver by inhibiting hepatic macrophage polarization to the M1 phenotype.
Topics: Animals; Cholesterol; Eosine Yellowish-(YS); Glucose; Insulin Resistance; Insulins; Lipopolysaccharides; Liver; Macrophages; Mice; Molecular Docking Simulation; Myeloid Differentiation Factor 88; NF-kappa B; Non-alcoholic Fatty Liver Disease; Pentoxifylline; Phenotype; Tea; Theobromine; Toll-Like Receptor 4; Triglycerides | 2022 |
Gypenosides counteract hepatic steatosis and intestinal barrier injury in rats with metabolic associated fatty liver disease by modulating the adenosine monophosphate activated protein kinase and Toll-like receptor 4/nuclear factor kappa B pathways.
Topics: Adenosine Monophosphate; AMP-Activated Protein Kinases; Animals; Caco-2 Cells; Eosine Yellowish-(YS); Fructose; Glucose; Gynostemma; Humans; Lipopolysaccharides; Liver; NF-kappa B; Non-alcoholic Fatty Liver Disease; Occludin; Plant Extracts; Rats; Rats, Sprague-Dawley; Toll-Like Receptor 4 | 2022 |
Automated quantification and architectural pattern detection of hepatic fibrosis in NAFLD.
Topics: Artificial Intelligence; Automation; Azo Compounds; Biopsy; Clinical Trials as Topic; Collagen; Eosine Yellowish-(YS); Fibrosis; Humans; Image Processing, Computer-Assisted; Liver; Liver Cirrhosis; Methyl Green; Non-alcoholic Fatty Liver Disease; Organ Dysfunction Scores; Pathologists; Portal Vein; Practice Patterns, Physicians'; Severity of Illness Index; Supervised Machine Learning | 2020 |
A large-scale internal validation study of unsupervised virtual trichrome staining technologies on nonalcoholic steatohepatitis liver biopsies.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Azo Compounds; Biopsy; Child; Clinical Decision-Making; Coloring Agents; Decision Support Techniques; Eosine Yellowish-(YS); Female; Hematoxylin; Humans; Image Interpretation, Computer-Assisted; Liver; Liver Cirrhosis; Male; Methyl Green; Microscopy; Middle Aged; Neural Networks, Computer; Non-alcoholic Fatty Liver Disease; Predictive Value of Tests; Reproducibility of Results; Retrospective Studies; Severity of Illness Index; Software; Staining and Labeling; Young Adult | 2021 |